Alder BioPharmaceuticals Reports First Quarter 2016 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St treads water as chips rise, megacaps fall ahead of Fed, Big Tech earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Alder BioPharma (ALDR) Misses Q1 EPS by 4c
April 28, 2016 4:45 PM EDTAlder BioPharma (NASDAQ: ALDR) reported Q1 EPS of ($0.76), $0.04 worse than the analyst estimate of ($0.72).
For earnings history and earnings-related data on Alder BioPharma (ALDR) click here.
... More


